렌치 바이러스 벡터 시장 : 제품 유형별, 최종 사용자별, 지역별 - 세계 산업 분석, 규모, 점유율, 성장, 동향 및 예측(2024-2032년)

Lentiviral Vectors Market by Product Type, End-Users, and Geography (North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa): Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2032

US $ 4,995 ￦ 7,211,000

Unprintable PDF & Excel (Single User License)

PDF, Excel 보고서를 1명만 이용할 수 있는 라이선스입니다. 텍스트의 복사, 인쇄가 불가능합니다.

US $ 7,295 ￦ 10,532,000

PDF & Excel (Multi User License)

PDF, Excel 보고서를 동일 기업 내 5명까지 이용할 수 있는 라이선스입니다. 텍스트의 Copy&Paste와 인쇄가 가능합니다.

US $ 8,495 ￦ 12,265,000

PDF & Excel (Corporate User License)

PDF, Excel 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 텍스트의 Copy&Paste와 인쇄가 가능합니다.

한글목차

Persistence Market Research는 최근 세계 렌치 바이러스 벡터 시장에 대한 심층 연구를 발표하여 주요 시장 역학, 성장 촉매제, 도전 과제 및 새로운 동향에 대한 종합적인 통찰력을 제공했습니다. 이 조사 보고서는 렌치 바이러스 벡터 시장에 대한 귀중한 전망을 제공하고 2024년부터 2032년까지 시장 궤적을 예측하는 고유한 데이터와 통계를 제시합니다.

렌치 바이러스 벡터 시장은 2024년부터 2032년까지 11.4%의 연평균 복합 성장률(CAGR)로 2024년 시장 규모는 1억 5,830만 달러, 2032년에는 4억 1,120만 달러에 달할 것으로 예상됩니다.

주요 인사이트

• 렌치 바이러스 벡터 시장 CAGR(2024-2032년) : 11.4%.
• 렌치 바이러스 벡터 시장 규모(2024년) : 1억 5,830만 달러
• 렌치 바이러스 벡터 시장 규모(2032년) : 4억 1,120만 달러

조사 범위 :

이 보고서는 전 세계 유전자 치료 및 생명공학 분야에서 렌티바이러스 벡터의 채택을 촉진하는 다양한 응용 분야와 기술 발전에 대해 자세히 설명합니다. 시장 성장 촉진요인, 시장 성장 억제요인, 시장 환경을 형성하는 기회와 같은 시장 역학을 평가합니다. 또한, 경쟁 정보 및 주요 시장 기업들이 채택하고 있는 사업 전략에 대한 전략적 고찰도 제공합니다.

시장 성장 촉진요인 :

렌치바이러스 벡터 시장은 유전성 질환의 유병률 증가, 유전자 치료 연구의 발전, 효과적인 치료 방법에 대한 수요 증가 등의 요인에 의해 주도되고 있습니다. 또한 생명 공학 부문의 확대와 연구 개발 이니셔티브에 대한 투자 증가는 시장 성장을 더욱 촉진할 것입니다.

시장 성장 억제요인

유망한 성장 전망에도 불구하고 렌티큘러 바이러스 벡터 시장에는 여러 가지 도전과제가 존재합니다. 여기에는 유전자 치료 제품과 관련된 규제 장애물, 바이러스 벡터와 관련된 안전성 문제, 대규모 벡터 생산의 복잡성 등이 포함됩니다. 또한, 높은 치료 비용과 제한된 접근성이 시장 확대의 걸림돌로 작용하고 있습니다.

시장 기회

렌치 바이러스 벡터 시장은 기술 혁신과 시장 침투에 유리한 기회를 가지고 있습니다. 벡터 설계 및 제조 기술의 지속적인 발전과 희귀질환 및 암 치료에 대한 응용 분야 확대와 함께 시장 기업에게 유망한 길을 제공합니다. 또한, 제품 개발 및 상용화를 위한 전략적 제휴 및 파트너십은 시장 전망을 더욱 밝게 하고 있습니다.

본 보고서에서 다룬 주요 질문들

• 렌치 바이러스 벡터 시장의 성장을 가속하는 주요 요인은?
• 기술의 발전은 렌치 바이러스 벡터 시장 경쟁 구도를 어떻게 변화시키고 있는가?
• 렌치 바이러스 벡터 세계 시장에서 예상되는 주요 시장 동향과 향후 전망은?
• 렌치 바이러스 벡터 시장을 선도하는 기업은?

목차

제1장 주요 요약

제2장 시장 개요

• 시장 범위/분류
• 시장의 정의/범위/제한
• 포함과 제외

제3장 주요 시장 동향

• 시장에 영향을 미치는 주요 동향
• 용도 혁신/개발 동향

제4장 중요 성공 요인

• 제품 채택 분석
• 주요 규제
• 제조업체의 주요 프로모션 전략
• PESTLE 분석
• Porter의 Five Forces 분석

제5장 시장 배경

• 거시경제 요인
• 예측 요인 - 관련성과 영향
• 시장 역학

제6장 COVID-19 위기 분석

• COVID-19의 현재 통계와 향후 영향 가능성
• 현재의 GDP 예측과 예상되는 영향
• COVID-19와 영향 분석
  • 제품별
  • 적응증별
  • 최종사용자별
• 2024년 시장 시나리오

제7장 세계의 렌티바이러스 벡터 시장 수요 가치 분석

• 과거 시장가치 분석(2019년-2023년)
• 현재 및 향후 시장가치 예측(2024년-2032년)
  • 전년대비 성장 동향 분석
  • 절대액 기회 분석

제8장 세계의 렌티바이러스 벡터 시장 분석 : 제품별

• 서론/주요 조사 결과
• 과거 시장가치 : 제품별(2019년-2023년)
• 현재 및 향후 시장가치 분석과 예측 : 제품별(2024년-2032년)
  • 키트
    • 렌티바이러스 패킹 시스템
    • 렌티바이러스 발현 시스템
    • 렌티바이러스 프로모터 키트
    • 렌티바이러스 융합 태그
  • 시약 및 소모품
• 제품별 시장의 매력 분석

제9장 세계의 렌티바이러스 벡터 시장 분석 : 적응증별

• 서론/주요 조사 결과
• 과거 시장 규모 분석 : 적응증별(2019년-2023년)
• 현재 및 향후 시장 규모 분석과 예측 : 적응증별(2024년-2032년)
  • 암
  • 유전성 질환
  • 감염증
  • 수의 질환
  • 기타
• 적응증별 매력 분석

제10장 세계의 렌티바이러스 벡터 시장 분석 : 최종사용자별

• 서론/주요 조사 결과
• 과거 시장 규모 분석 : 최종사용자별(2019년-2023년)
• 현재 및 향후 시장 규모 분석과 예측 : 최종사용자별(2024년-2032년)
  • 바이오테크놀러지 기업
  • 제약회사
  • 수탁 연구기관
  • 학술연구기관
• 최종사용자별 시장의 매력 분석

제11장 렌티바이러스 벡터 시장 분석 : 지역별

• 서론
• 과거 시장 규모 분석 : 지역별(2019년-2023년)
• 현재 시장 규모 분석과 예측 : 지역별(2024년-2032년)
  • 북미
  • 라틴아메리카
  • 유럽
  • 동아시아
  • 남아시아
  • 오세아니아
  • 중동 및 아프리카(MEA)
• 지역별 시장의 매력 분석

제12장 북미의 렌티바이러스 벡터 시장 분석

제13장 라틴아메리카의 렌티바이러스 벡터 시장 분석

제14장 유럽의 렌티바이러스 벡터 시장 분석

제15장 남아시아의 렌티바이러스 벡터 시장 분석

제16장 동아시아의 렌티바이러스 벡터 시장 분석

제17장 오세아니아의 렌티바이러스 벡터 시장 분석

제18장 중동 및 아프리카의 렌티바이러스 벡터 시장 분석

제19장 경쟁 분석

• 경쟁 대시보드
• 경쟁 벤치마킹
• 경쟁 상세
  • Thermo Fisher Scientific
  • PerkinElimer Inc.
  • GENEMEDI
  • Takara Bio Inc.
  • Sino Biological Inc.
  • OriGene Technologies, Inc.
  • Charles River Laboratories
  • Cell Biolabs, Inc.
  • Applied Biological Materials Inc.

제20장 전제와 두자어

제21장 조사 방법

LSH

영문 목차

영문목차

Persistence Market Research has recently unveiled a detailed examination of the global Lentiviral Vectors Market, providing a comprehensive insight into the crucial market dynamics, growth catalysts, challenges, and emerging trends. This report furnishes invaluable perspectives into the Lentiviral Vectors Market, presenting exclusive data and statistics projecting the market's trajectory from 2024 to 2032.

The CAGR for the Lentiviral Vectors Market from 2024 to 2032 is 11.4%, with a market size of US$ 158.3 million in 2024 and projected to grow to US$ 411.2 million by 2032.

Key Insights:

• Lentiviral Vectors Market CAGR (2024-2032): 11.4%
• Lentiviral Vectors Market Size (2024): US$ 158.3 Million
• Lentiviral Vectors Market Size (2032): US$ 411.2 Million

Report Scope:

This report dives into various applications and technological advancements propelling the adoption of lentiviral vectors in gene therapy and biotechnology sectors worldwide. It evaluates market dynamics, including drivers, restraints, and opportunities shaping the market landscape. Additionally, it offers strategic insights into competitive intelligence and business strategies adopted by key market players.

Market Growth Drivers:

The Lentiviral Vectors Market is driven by factors such as the increasing prevalence of genetic disorders, advancements in gene therapy research, and the growing demand for effective treatment modalities. Moreover, the expanding biotechnology sector and rising investments in R&D initiatives further fuel market growth.

Market Restraints:

Despite promising growth prospects, challenges exist in the Lentiviral Vectors Market. These include regulatory hurdles associated with gene therapy products, safety concerns related to viral vectors, and complexities in large-scale vector production. Additionally, high treatment costs and limited accessibility hinder market expansion.

Market Opportunities:

The Lentiviral Vectors Market presents lucrative opportunities for innovation and market penetration. Continued advancements in vector design and manufacturing technologies, coupled with expanding applications in rare diseases and cancer therapy, offer promising avenues for market players. Moreover, strategic collaborations and partnerships for product development and commercialization enhance market prospects.

Key Questions Answered in the Report:

• What are the primary factors driving the growth of the Lentiviral Vectors Market?
• How are technological advancements reshaping the competitive landscape of the Lentiviral Vectors Market?
• What are the key market trends and future prospects anticipated in the global Lentiviral Vectors Market?
• Who are the leading players in the Lentiviral Vectors Market?

Competitive Intelligence and Business Strategy:

The Lentiviral Vectors Market is characterized by intense competition, with key players such as Thermo Fisher Scientific, Merck KGaA, and SIRION Biotech GmbH dominating. Thermo Fisher Scientific is renowned for its comprehensive lentiviral vector platforms tailored to research and clinical applications. Merck KGaA leverages its expertise in bioprocessing and gene editing technologies, while SIRION Biotech GmbH focuses on custom vector design services. Emerging players like OriGene Technologies and GenScript Biotech Corporation concentrate on niche markets, such as lentiviral-based gene delivery systems and viral vector manufacturing services. Each competitor brings unique strengths and technological capabilities to the table, driving innovation and shaping the dynamic landscape of the Lentiviral Vectors industry.

Key Companies Profiled:

• Thermo Fisher Scientific
• PerkinElimer Inc.
• GENEMEDI
• Takara Bio Inc.
• Sino Biological Inc.
• OriGene Technologies, Inc.
• Charles River Laboratories
• Cell Biolabs, Inc.
• Applied Biological Materials Inc.

Lentiviral Vectors Market Segmentation:

Lentiviral Vectors Market by Product:

• Lentiviral Vector Kits

Lentiviral Packing Systems

Lentiviral Expression Systems

Lentiviral Promoter Kits

Lentiviral Fusion Tags

• Reagents & Consumables

Lentiviral Vectors Market by Indication:

• Cancer
• Genetic Disorders
• Infectious Diseases
• Veterinary Diseases
• Others

Lentiviral Vectors Market by End User:

• Biotechnology Companies
• Pharmaceutical Companies
• Contract Research Organizations (CROs)
• Academic and Research Institutes

Lentiviral Vectors Market by Region:

• North America Lentiviral Vectors Market
• Latin America Lentiviral Vectors Market
• Europe Lentiviral Vectors Market
• South Asia Lentiviral Vectors Market
• East Asia Lentiviral Vectors Market
• Oceania Lentiviral Vectors Market
• Middle East & Africa Lentiviral Vectors Market

Table of Contents

1. Executive Summary

• 1.1. Global Market Outlook
• 1.2. Demand Side Trends
• 1.3. Supply Side Trends
• 1.4. Analysis and Recommendations

2. Market Overview

• 2.1. Market Coverage / Taxonomy
• 2.2. Market Definition / Scope / Limitations
• 2.3. Inclusion and Exclusions

3. Key Market Trends

• 3.1. Key Trends Impacting the Market
• 3.2. Application Innovation / Development Trends

4. Key Success Factors

• 4.1. Product Adoption Analysis
• 4.2. Key Regulations
• 4.3. Key Promotional Strategies by Manufacturers
• 4.4. PESTLE Analysis
• 4.5. Porter's Analysis

5. Market Background

• 5.1. Macro-Economic Factors
  • 5.1.1. Global GDP Outlook
  • 5.1.2. Per-Capita Healthcare Expenditure
• 5.2. Forecast Factors - Relevance & Impact
  • 5.2.1. COVID-19 Pandemic
  • 5.2.2. Increasing Prevalence of Cancer
  • 5.2.3. Rise in R&D Investments
  • 5.2.4. Top Lentiviral Vectors Companies and Their Historical Growth
  • 5.2.5. Rise in Number of Clinical Studies
  • 5.2.6. Increasing Investment in Lentiviral Vectors Research
  • 5.2.7. GDP Growth
  • 5.2.8. Adoption Rate of Lentiviral Vectors Products
• 5.3. Market Dynamics
  • 5.3.1. Drivers
  • 5.3.2. Restraints
  • 5.3.3. Opportunity Analysis

6. COVID-19 Crisis Analysis

• 6.1. Current COVID-19 Statistics and Probable Future Impact
• 6.2. Current GDP Projection and Probable Impact
• 6.3. COVID-19 and Impact Analysis
  • 6.3.1. By Product
  • 6.3.2. By Indication
  • 6.3.3. By End User
• 6.4. 2024 Market Scenario

7. Global Lentiviral Vectors Market Demand Value (US$ Mn) Analysis 2019-2023 and Forecast, 2024-2032

• 7.1. Historical Market Value (US$ Mn) Analysis, 2019-2023
• 7.2. Current and Future Market Value (US$ Mn) Projections, 2024-2032
  • 7.2.1. Y-o-Y Growth Trend Analysis
  • 7.2.2. Absolute $ Opportunity Analysis

8. Global Lentiviral Vectors Market Analysis 2019-2023 and Forecast 2024-2032, By Product

• 8.1. Introduction / Key Findings
• 8.2. Historical Market Value (US$ Mn) By Product, 2019-2023
• 8.3. Current and Future Market Value (US$ Mn) Analysis and Forecast By Product, 2024-2032
  • 8.3.1. Kits
    • 8.3.1.1. Lentiviral Packing System
    • 8.3.1.2. Lentiviral Expression System
    • 8.3.1.3. Lentiviral Promoter Kit
    • 8.3.1.4. Lentiviral Fusion Tags
  • 8.3.2. Reagents & Consumables
• 8.4. Market Attractiveness Analysis By Product

9. Global Lentiviral Vectors Market Analysis 2019-2023 and Forecast 2024-2032, By Indication

• 9.1. Introduction / Key Findings
• 9.2. Historical Market Size (US$ Mn) Analysis By Indication, 2019-2023
• 9.3. Current and Future Market Value (US$ Mn) Analysis and Forecast By Indication, 2024-2032
  • 9.3.1. Cancer
  • 9.3.2. Genetic Disorder
  • 9.3.3. Infectious Disease
  • 9.3.4. Veterinary Disease
  • 9.3.5. Others
• 9.4. Attractiveness Analysis By Indication

10. Global Lentiviral Vectors Market Analysis 2019-2023 and Forecast 2024-2032, By End User

• 10.1. Introduction / Key Findings
• 10.2. Historical Market Size (US$ Mn) Analysis By End User, 2019-2023
• 10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By End User, 2024-2032
  • 10.3.1. Biotechnology Companies
  • 10.3.2. Pharmaceutical Companies
  • 10.3.3. Contract Research Organization (CRO)
  • 10.3.4. Academic and Research Institutes
• 10.4. Market Attractiveness Analysis By End User

11. Global Lentiviral Vectors Market Analysis 2019-2023 and Forecast 2024-2032, By Region

• 11.1. Introduction
• 11.2. Historical Market Value (US$ Mn) Analysis By Region, 2019-2023
• 11.3. Current Market Value (US$ Mn) Analysis and Forecast By Region, 2024-2032
  • 11.3.1. North America
  • 11.3.2. Latin America
  • 11.3.3. Europe
  • 11.3.4. East Asia
  • 11.3.5. South Asia
  • 11.3.6. Oceania
  • 11.3.7. Middle East and Africa (MEA)
• 11.4. Market Attractiveness Analysis By Region

12. North America Lentiviral Vectors Market Analysis 2019-2023 and Forecast 2024-2032

• 12.1. Introduction
• 12.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2019-2023
• 12.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2024-2032
  • 12.3.1. By Country
    • 12.3.1.1. U.S.
    • 12.3.1.2. Canada
  • 12.3.2. By Product
  • 12.3.3. By Indication
  • 12.3.4. By End User
• 12.4. Market Attractiveness Analysis
  • 12.4.1. By Country
  • 12.4.2. By Product
  • 12.4.3. By Indication
  • 12.4.4. By End User
• 12.5. Key Market Participants - Intensity Mapping
• 12.6. Drivers and Restraints - Impact Analysis
• 12.7. Country Level Analysis & Forecast
  • 12.7.1. U.S. Lentiviral Vectors Market
    • 12.7.1.1. Introduction
    • 12.7.1.2. Market Analysis and Forecast by Market Taxonomy
      • 12.7.1.2.1. By Product
      • 12.7.1.2.2. By Indication
      • 12.7.1.2.3. By End User
  • 12.7.2. Canada Lentiviral Vectors Market
    • 12.7.2.1. Introduction
    • 12.7.2.2. Market Analysis and Forecast by Market Taxonomy
      • 12.7.2.2.1. By Product
      • 12.7.2.2.2. By Indication
      • 12.7.2.2.3. By End User

13. Latin America Lentiviral Vectors Market Analysis 2019-2023 and Forecast 2024-2032

• 13.1. Introduction
• 13.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2019-2023
• 13.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2024-2032
  • 13.3.1. By Country
    • 13.3.1.1. Brazil
    • 13.3.1.2. Mexico
    • 13.3.1.3. Argentina
    • 13.3.1.4. Rest of Latin America
  • 13.3.2. By Product
  • 13.3.3. By Indication
  • 13.3.4. By End User
• 13.4. Market Attractiveness Analysis
  • 13.4.1. By Country
  • 13.4.2. By Product
  • 13.4.3. By Indication
  • 13.4.4. By End User
• 13.5. Key Market Participants - Intensity Mapping
• 13.6. Drivers and Restraints - Impact Analysis
• 13.7. Country Level Analysis & Forecast
  • 13.7.1. Brazil Lentiviral Vectors Market
    • 13.7.1.1. Introduction
    • 13.7.1.2. Market Analysis and Forecast by Market Taxonomy
      • 13.7.1.2.1. By Product
      • 13.7.1.2.2. By Indication
      • 13.7.1.2.3. By End User
  • 13.7.2. Mexico Lentiviral Vectors Market
    • 13.7.2.1. Introduction
    • 13.7.2.2. Market Analysis and Forecast by Market Taxonomy
      • 13.7.2.2.1. By Product
      • 13.7.2.2.2. By Indication
      • 13.7.2.2.3. By End User
  • 13.7.3. Argentina Lentiviral Vectors Market
    • 13.7.3.1. Introduction
    • 13.7.3.2. Market Analysis and Forecast by Market Taxonomy
      • 13.7.3.2.1. By Product
      • 13.7.3.2.2. By Indication
      • 13.7.3.2.3. By End User

14. Europe Lentiviral Vectors Market Analysis 2019-2023 and Forecast 2024-2032

• 14.1. Introduction
• 14.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2019-2023
• 14.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2024-2032
  • 14.3.1. By Country
    • 14.3.1.1. Germany
    • 14.3.1.2. Italy
    • 14.3.1.3. France
    • 14.3.1.4. U.K.
    • 14.3.1.5. Spain
    • 14.3.1.6. BENELUX
    • 14.3.1.7. Russia
    • 14.3.1.8. Rest of Europe
  • 14.3.2. By Product
  • 14.3.3. By Indication
  • 14.3.4. By End User
• 14.4. Market Attractiveness Analysis
  • 14.4.1. By Country
  • 14.4.2. By Product
  • 14.4.3. By Indication
  • 14.4.4. By End User
• 14.5. Key Market Participants - Intensity Mapping
• 14.6. Drivers and Restraints - Impact Analysis
• 14.7. Country Level Analysis & Forecast
  • 14.7.1. Germany Lentiviral Vectors Market
    • 14.7.1.1. Introduction
    • 14.7.1.2. Market Analysis and Forecast by Market Taxonomy
      • 14.7.1.2.1. By Product
      • 14.7.1.2.2. By Indication
      • 14.7.1.2.3. By End User
  • 14.7.2. Italy Lentiviral Vectors Market
    • 14.7.2.1. Introduction
    • 14.7.2.2. Market Analysis and Forecast by Market Taxonomy
      • 14.7.2.2.1. By Product
      • 14.7.2.2.2. By Indication
      • 14.7.2.2.3. By End User
  • 14.7.3. France Lentiviral Vectors Market
    • 14.7.3.1. Introduction
    • 14.7.3.2. Market Analysis and Forecast by Market Taxonomy
      • 14.7.3.2.1. By Product
      • 14.7.3.2.2. By Indication
      • 14.7.3.2.3. By End User
  • 14.7.4. U.K. Lentiviral Vectors Market
    • 14.7.4.1. Introduction
    • 14.7.4.2. Market Analysis and Forecast by Market Taxonomy
      • 14.7.4.2.1. By Product
      • 14.7.4.2.2. By Indication
      • 14.7.4.2.3. By End User
  • 14.7.5. Spain Lentiviral Vectors Market
    • 14.7.5.1. Introduction
    • 14.7.5.2. Market Analysis and Forecast by Market Taxonomy
      • 14.7.5.2.1. By Product
      • 14.7.5.2.2. By Indication
      • 14.7.5.2.3. By End User
  • 14.7.6. BENELUX Union Lentiviral Vectors Market
    • 14.7.6.1. Introduction
    • 14.7.6.2. Market Analysis and Forecast by Market Taxonomy
      • 14.7.6.2.1. By Product
      • 14.7.6.2.2. By Indication
      • 14.7.6.2.3. By End User
  • 14.7.7. Russia Lentiviral Vectors Market
    • 14.7.7.1. Introduction
    • 14.7.7.2. Market Analysis and Forecast by Market Taxonomy
      • 14.7.7.2.1. By Product
      • 14.7.7.2.2. By Indication
      • 14.7.7.2.3. By End User

15. South Asia Lentiviral Vectors Market Analysis 2019-2023 and Forecast 2024-2032

• 15.1. Introduction
• 15.2. Historical Market Size (US$ Mn Analysis By Market Taxonomy, 2019-2023
• 15.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2024-2032
  • 15.3.1. By Country
    • 15.3.1.1. India
    • 15.3.1.2. Thailand
    • 15.3.1.3. Indonesia
    • 15.3.1.4. Malaysia
    • 15.3.1.5. Rest of South Asia
  • 15.3.2. By Product
  • 15.3.3. By Indication
  • 15.3.4. By End User
• 15.4. Market Attractiveness Analysis
  • 15.4.1. By Country
  • 15.4.2. By Product
  • 15.4.3. By Indication
  • 15.4.4. By End User
• 15.5. Key Market Participants - Intensity Mapping
• 15.6. Drivers and Restraints - Impact Analysis
• 15.7. Country Level Analysis & Forecast
  • 15.7.1. India Lentiviral Vectors Market
    • 15.7.1.1. Introduction
    • 15.7.1.2. Market Analysis and Forecast by Market Taxonomy
      • 15.7.1.2.1. By Product
      • 15.7.1.2.2. By Indication
      • 15.7.1.2.3. By End User
  • 15.7.2. Indonesia Lentiviral Vectors Market
    • 15.7.2.1. Introduction
    • 15.7.2.2. Market Analysis and Forecast by Market Taxonomy
      • 15.7.2.2.1. By Product
      • 15.7.2.2.2. By Indication
      • 15.7.2.2.3. By End User
  • 15.7.3. Malaysia Lentiviral Vectors Market
    • 15.7.3.1. Introduction
    • 15.7.3.2. Market Analysis and Forecast by Market Taxonomy
      • 15.7.3.2.1. By Product
      • 15.7.3.2.2. By Indication
      • 15.7.3.2.3. By End User
  • 15.7.4. Thailand Lentiviral Vectors Market
    • 15.7.4.1. Introduction
    • 15.7.4.2. Market Analysis and Forecast by Market Taxonomy
      • 15.7.4.2.1. By Product
      • 15.7.4.2.2. By Indication
      • 15.7.4.2.3. By End User

16. East Asia Lentiviral Vectors Market Analysis 2019-2023 and Forecast 2024-2032

• 16.1. Introduction
• 16.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2019-2023
• 16.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2024-2032
  • 16.3.1. By Country
    • 16.3.1.1. China
    • 16.3.1.2. Japan
    • 16.3.1.3. South Korea
  • 16.3.2. By Product
  • 16.3.3. By Indication
  • 16.3.4. By End User
• 16.4. Market Attractiveness Analysis
  • 16.4.1. By Country
  • 16.4.2. By Product
  • 16.4.3. By Indication
  • 16.4.4. By End User
• 16.5. Key Market Participants - Intensity Mapping
• 16.6. Drivers and Restraints - Impact Analysis
• 16.7. Country Level Analysis & Forecast
  • 16.7.1. China Lentiviral Vectors Market
    • 16.7.1.1. Introduction
    • 16.7.1.2. Market Analysis and Forecast by Market Taxonomy
      • 16.7.1.2.1. By Product
      • 16.7.1.2.2. By Indication
      • 16.7.1.2.3. By End User
  • 16.7.2. Japan Lentiviral Vectors Market
    • 16.7.2.1. Introduction
    • 16.7.2.2. Market Analysis and Forecast by Market Taxonomy
      • 16.7.2.2.1. By Product
      • 16.7.2.2.2. By Indication
      • 16.7.2.2.3. By End User
  • 16.7.3. South Korea Lentiviral Vectors Market
    • 16.7.3.1. Introduction
    • 16.7.3.2. Market Analysis and Forecast by Market Taxonomy
      • 16.7.3.2.1. By Product
      • 16.7.3.2.2. By Indication
      • 16.7.3.2.3. By End User

17. Oceania Lentiviral Vectors Market Analysis 2019-2023 and Forecast 2024-2032

• 17.1. Introduction
• 17.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2019-2023
• 17.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2024-2032
  • 17.3.1. By Country
    • 17.3.1.1. Australia
    • 17.3.1.2. New Zealand
  • 17.3.2. By Product
  • 17.3.3. By Indication
  • 17.3.4. By End User
• 17.4. Market Attractiveness Analysis
  • 17.4.1. By Country
  • 17.4.2. By Product
  • 17.4.3. By Indication
  • 17.4.4. By End User
• 17.5. Key Market Participants - Intensity Mapping
• 17.6. Drivers and Restraints - Impact Analysis
• 17.7. Country Level Analysis & Forecast
  • 17.7.1. Australia Lentiviral Vectors Market
    • 17.7.1.1. Introduction
    • 17.7.1.2. Market Analysis and Forecast by Market Taxonomy
      • 17.7.1.2.1. By Product
      • 17.7.1.2.2. By Indication
      • 17.7.1.2.3. By End User
  • 17.7.2. New Zealand Lentiviral Vectors Market
    • 17.7.2.1. Introduction
    • 17.7.2.2. Market Analysis and Forecast by Market Taxonomy
      • 17.7.2.2.1. By Product
      • 17.7.2.2.2. By Indication
      • 17.7.2.2.3. By End User

18. Middle East and Africa (MEA) Lentiviral Vectors Market Analysis 2019-2023 and Forecast 2024-2032

• 18.1. Introduction
• 18.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2019-2023
• 18.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2024-2032
  • 18.3.1. By Country
    • 18.3.1.1. GCC Countries
    • 18.3.1.2. Turkey
    • 18.3.1.3. South Africa
    • 18.3.1.4. Rest of Middle East and Africa
  • 18.3.2. By Product
  • 18.3.3. By Indication
  • 18.3.4. By End User
• 18.4. Market Attractiveness Analysis
  • 18.4.1. By Country
  • 18.4.2. By Product
  • 18.4.3. By Indication
  • 18.4.4. By End User
• 18.5. Key Market Participants - Intensity Mapping
• 18.6. Drivers and Restraints - Impact Analysis
• 18.7. Country Level Analysis & Forecast
  • 18.7.1. GCC Countries Lentiviral Vectors Market
    • 18.7.1.1. Introduction
    • 18.7.1.2. Market Analysis and Forecast by Market Taxonomy
      • 18.7.1.2.1. By Product
      • 18.7.1.2.2. By Indication
      • 18.7.1.2.3. By End User
  • 18.7.2. Turkey Lentiviral Vectors Market
    • 18.7.2.1. Introduction
    • 18.7.2.2. Market Analysis and Forecast by Market Taxonomy
      • 18.7.2.2.1. By Product
      • 18.7.2.2.2. By Indication
      • 18.7.2.2.3. By End User
  • 18.7.3. South Africa Lentiviral Vectors Market
    • 18.7.3.1. Introduction
    • 18.7.3.2. Market Analysis and Forecast by Market Taxonomy
      • 18.7.3.2.1. By Product
      • 18.7.3.2.2. By Indication
      • 18.7.3.2.3. By End User

19. Competition Analysis

• 19.1. Competition Dashboard
• 19.2. Competition Benchmarking
• 19.3. Competition Deep Dive
  • 19.3.1. Thermo Fisher Scientific
    • 19.3.1.1. Overview
    • 19.3.1.2. Product Portfolio
    • 19.3.1.3. Profitability by Market Segments (Drug type/Channel/Region)
    • 19.3.1.4. Sales Footprint
    • 19.3.1.5. Strategy Overview
      • 19.3.1.5.1. Marketing Strategy
      • 19.3.1.5.2. Drug type Strategy
      • 19.3.1.5.3. Channel Strategy
  • 19.3.2. PerkinElimer Inc.
    • 19.3.2.1. Overview
    • 19.3.2.2. Product Portfolio
    • 19.3.2.3. Profitability by Market Segments (Drug type/Channel/Region)
    • 19.3.2.4. Sales Footprint
    • 19.3.2.5. Strategy Overview
      • 19.3.2.5.1. Marketing Strategy
      • 19.3.2.5.2. Drug type Strategy
      • 19.3.2.5.3. Channel Strategy
  • 19.3.3. GENEMEDI
    • 19.3.3.1. Overview
    • 19.3.3.2. Product Portfolio
    • 19.3.3.3. Profitability by Market Segments (Drug type/Channel/Region)
    • 19.3.3.4. Sales Footprint
    • 19.3.3.5. Strategy Overview
      • 19.3.3.5.1. Marketing Strategy
      • 19.3.3.5.2. Drug type Strategy
      • 19.3.3.5.3. Channel Strategy
  • 19.3.4. Takara Bio Inc.
    • 19.3.4.1. Overview
    • 19.3.4.2. Product Portfolio
    • 19.3.4.3. Profitability by Market Segments (Drug type/Channel/Region)
    • 19.3.4.4. Sales Footprint
    • 19.3.4.5. Strategy Overview
      • 19.3.4.5.1. Marketing Strategy
      • 19.3.4.5.2. Drug type Strategy
      • 19.3.4.5.3. Channel Strategy
  • 19.3.5. Sino Biological Inc.
    • 19.3.5.1. Overview
    • 19.3.5.2. Product Portfolio
    • 19.3.5.3. Profitability by Market Segments (Drug type/Channel/Region)
    • 19.3.5.4. Sales Footprint
    • 19.3.5.5. Strategy Overview
      • 19.3.5.5.1. Marketing Strategy
      • 19.3.5.5.2. Drug type Strategy
      • 19.3.5.5.3. Channel Strategy
  • 19.3.6. OriGene Technologies, Inc.
    • 19.3.6.1. Overview
    • 19.3.6.2. Product Portfolio
    • 19.3.6.3. Profitability by Market Segments (Drug type/Channel/Region)
    • 19.3.6.4. Sales Footprint
    • 19.3.6.5. Strategy Overview
      • 19.3.6.5.1. Marketing Strategy
      • 19.3.6.5.2. Drug type Strategy
      • 19.3.6.5.3. Channel Strategy
  • 19.3.7. Charles River Laboratories
    • 19.3.7.1. Overview
    • 19.3.7.2. Product Portfolio
    • 19.3.7.3. Profitability by Market Segments (Drug type/Channel/Region)
    • 19.3.7.4. Sales Footprint
    • 19.3.7.5. Strategy Overview
      • 19.3.7.5.1. Marketing Strategy
      • 19.3.7.5.2. Drug type Strategy
      • 19.3.7.5.3. Channel Strategy
  • 19.3.8. Cell Biolabs, Inc.
    • 19.3.8.1. Overview
    • 19.3.8.2. Product Portfolio
    • 19.3.8.3. Profitability by Market Segments (Drug type/Channel/Region)
    • 19.3.8.4. Sales Footprint
    • 19.3.8.5. Strategy Overview
      • 19.3.8.5.1. Marketing Strategy
      • 19.3.8.5.2. Drug type Strategy
      • 19.3.8.5.3. Channel Strategy
  • 19.3.9. Applied Biological Materials Inc.
    • 19.3.9.1. Overview
    • 19.3.9.2. Product Portfolio
    • 19.3.9.3. Profitability by Market Segments (Drug type/Channel/Region)
    • 19.3.9.4. Sales Footprint
    • 19.3.9.5. Strategy Overview
      • 19.3.9.5.1. Marketing Strategy
      • 19.3.9.5.2. Drug type Strategy
      • 19.3.9.5.3. Channel Strategy

20. Assumptions and Acronyms Used

21. Research Methodology

관련자료